LT3263110T - Tabletė, apimanti metoksikarbamido darinį ir manitolio daleles - Google Patents

Tabletė, apimanti metoksikarbamido darinį ir manitolio daleles

Info

Publication number
LT3263110T
LT3263110T LTEPPCT/JP2016/055540T LT16755593T LT3263110T LT 3263110 T LT3263110 T LT 3263110T LT 16755593 T LT16755593 T LT 16755593T LT 3263110 T LT3263110 T LT 3263110T
Authority
LT
Lithuania
Prior art keywords
methoxyurea
tablet
derivative
mannitol particles
mannitol
Prior art date
Application number
LTEPPCT/JP2016/055540T
Other languages
English (en)
Inventor
Ikuro YAMANE
Yukihiro Nomura
Yutaka Nishimoto
Wataru Hoshina
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56789547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3263110(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of LT3263110T publication Critical patent/LT3263110T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/JP2016/055540T 2015-02-26 2016-02-25 Tabletė, apimanti metoksikarbamido darinį ir manitolio daleles LT3263110T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015037462 2015-02-26
PCT/JP2016/055540 WO2016136849A1 (ja) 2015-02-26 2016-02-25 固形製剤

Publications (1)

Publication Number Publication Date
LT3263110T true LT3263110T (lt) 2023-07-10

Family

ID=56789547

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/JP2016/055540T LT3263110T (lt) 2015-02-26 2016-02-25 Tabletė, apimanti metoksikarbamido darinį ir manitolio daleles

Country Status (23)

Country Link
US (2) US10350170B2 (lt)
EP (2) EP3263110B1 (lt)
JP (1) JP6730978B2 (lt)
CN (1) CN107249590A (lt)
AU (1) AU2016224503B2 (lt)
BR (1) BR112017018173A2 (lt)
CA (1) CA2978223A1 (lt)
CY (1) CY1126118T1 (lt)
DK (1) DK3263110T3 (lt)
ES (1) ES2950995T3 (lt)
FI (1) FI3263110T3 (lt)
HR (1) HRP20230613T1 (lt)
HU (1) HUE062269T2 (lt)
IL (1) IL254132B (lt)
LT (1) LT3263110T (lt)
MX (1) MX2017010945A (lt)
MY (1) MY180680A (lt)
PL (1) PL3263110T3 (lt)
PT (1) PT3263110T (lt)
RS (1) RS64377B1 (lt)
SI (1) SI3263110T1 (lt)
TW (1) TWI744224B (lt)
WO (1) WO2016136849A1 (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2900675T1 (sl) 2012-09-28 2019-06-28 Takeda Pharmaceutical Company Limited Postopek za pridobivanje tienopirimidin derivata
MA46361A (fr) * 2016-09-30 2021-03-31 Myovant Sciences Gmbh Traitement du cancer de la prostate
JP7043503B2 (ja) 2016-09-30 2022-03-29 ミオバント サイエンシズ ゲーエムベーハー 子宮筋腫及び子宮内膜症を治療する方法
US11306104B2 (en) 2018-03-14 2022-04-19 Teva Pharmaceuticals International Gmbh Solid state forms of Relugolix
CN114174302A (zh) 2019-08-02 2022-03-11 庄信万丰股份有限公司 瑞卢戈利的固态形式
US20230183205A1 (en) 2020-05-15 2023-06-15 Shionogi & Co., Ltd. Pharmaceutical composition in which production of impurities is suppressed
MX2022015003A (es) 2020-05-29 2023-03-03 Myovant Sciences Gmbh Formas de dosificacion oral solidas de combinacion de antagonistas de la hormona liberadora de gonadotropina.
EP4243829A1 (en) 2020-11-11 2023-09-20 Myovant Sciences GmbH Methods of administering relugolix
WO2023066941A1 (en) 2021-10-18 2023-04-27 Myovant Sciences Gmbh Crystalline form of an ethanol solvate of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea
CN115671069A (zh) * 2022-11-24 2023-02-03 北京鑫开元医药科技有限公司 一种瑞卢戈利片剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW284688B (lt) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3854648B2 (ja) 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
TWI225863B (en) 1999-03-24 2005-01-01 Takeda Chemical Industries Ltd Thienopyrimidine compounds, their production and use
JP5072166B2 (ja) 2002-01-30 2012-11-14 武田薬品工業株式会社 チエノピリミジン化合物、その製造法および用途
WO2003064429A1 (fr) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
RU2318518C2 (ru) * 2002-02-26 2008-03-10 Астразенека Аб Фармацевтическая композиция, обладающая антипролиферативным действием (варианты), способ ее получения и способы с ее использованием
KR101074462B1 (ko) 2003-01-29 2011-10-18 다케다 야쿠힌 고교 가부시키가이샤 티에노피리미딘 화합물 및 그 용도
JP4039574B2 (ja) 2003-01-29 2008-01-30 武田薬品工業株式会社 チエノピリミジン化合物およびその用途
JP2006035365A (ja) * 2004-07-26 2006-02-09 Hitachi Koki Co Ltd 携帯用切断工具
EP2329823A4 (en) * 2008-09-03 2013-04-03 Takeda Pharmaceutical METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
JP2015037462A (ja) 2012-06-01 2015-02-26 株式会社コナミデジタルエンタテインメント ゲーム装置、ゲーム方法、及びプログラム
SI2900675T1 (sl) 2012-09-28 2019-06-28 Takeda Pharmaceutical Company Limited Postopek za pridobivanje tienopirimidin derivata
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته

Also Published As

Publication number Publication date
PT3263110T (pt) 2023-08-01
US20200000730A1 (en) 2020-01-02
HUE062269T2 (hu) 2023-10-28
US20180036250A1 (en) 2018-02-08
JP6730978B2 (ja) 2020-07-29
AU2016224503A1 (en) 2017-09-14
SI3263110T1 (sl) 2023-09-29
TW201639575A (zh) 2016-11-16
CY1126118T1 (el) 2023-11-15
IL254132B (en) 2020-02-27
HRP20230613T1 (hr) 2023-09-29
FI3263110T3 (fi) 2023-07-25
AU2016224503B2 (en) 2021-07-08
NZ735026A (en) 2021-09-24
EP3263110A1 (en) 2018-01-03
CN107249590A (zh) 2017-10-13
BR112017018173A2 (pt) 2018-04-10
JPWO2016136849A1 (ja) 2017-12-07
EP4233847A1 (en) 2023-08-30
EP3263110B1 (en) 2023-05-10
RS64377B1 (sr) 2023-08-31
IL254132A0 (en) 2017-10-31
EP3263110A4 (en) 2018-11-07
MX2017010945A (es) 2018-07-06
ES2950995T3 (es) 2023-10-17
US10350170B2 (en) 2019-07-16
CA2978223A1 (en) 2016-09-01
MY180680A (en) 2020-12-06
PL3263110T3 (pl) 2023-11-06
TWI744224B (zh) 2021-11-01
WO2016136849A1 (ja) 2016-09-01
DK3263110T3 (da) 2023-07-31

Similar Documents

Publication Publication Date Title
IL249186B (en) Anti-cd20 glycoantibodies and their uses
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
HUE062269T2 (hu) Metoxikarbamid-származékot és mannit részecskéket tartalmazó tabletta
AU356804S (en) Tablet
HK1252026A1 (zh) 藥物組合及其應用
HRP20181507T1 (hr) Modificirana sulfamidaza i njena proizvodnja
IL254818A0 (en) Ribociclib tablet
IL253457A0 (en) Polymyxin derivatives, preparations containing them and their uses
PL3328361T3 (pl) Cząstki nanożywicy zawierające lek
HK1249857A1 (zh) 片劑
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
PL3156713T3 (pl) Podstawa telewizora i telewizor o płaskim ekranie
GB201420300D0 (en) Tablet
IL250160A0 (en) medicinal substance
AU356801S (en) Tablet
ZA201708393B (en) Large particles
EP3431079C0 (en) COMPRESSED
GB201511252D0 (en) Tablet
TWM532873U (en) Tablet structure
GB201505546D0 (en) Incinerators and chimleys
GB201419354D0 (en) Pharmaceutical extracts and uses thereof
AU356805S (en) Tablet
GB201411471D0 (en) Tablet